Author

Jining Dong

Observed name: J. Dong

OpenAlex ID: A5034849779

35O Overall survival of niraparib with individualized starting dose as maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer adjusted for subsequent PARPi use in placebo group: Results from an ad hoc interim analysis for the phase III NORA study

2023 · X. Wu, J. Zhu, et al. · ESMO Open · 1

Works count: 1

Citation count: 1

H-index: 1

I10-index: